Specialist pharmacy BioMatrix SpRx revealed on Wednesday the completion of the acquisition of Elwyn Pharmacy Group for undisclosed amount.
Located in Garnet Valley, Pennsylvania, southwest of Philadelphia, Elwyn Pharmacy Group provides a complete range of specialty pharmacy and infusion services. It treats a wide array of complex disease states including Multiple Sclerosis, Hepatitis C and other GI related diseases, Oncology/Cancer, bleeding disorders, Rheumatoid Arthritis, Psoriasis and HIV. The Elwyn Pharmacy Group includes Elwyn Pharmacy, Glen Rock Medical Pharmacy, Elwyn Specialty Care, and Med Center Specialty Pharmacy.
With this acquisition, BioMatrix has expanded their services into complementary therapeutic categories requiring the same high-touch services they are accustomed to providing. The company has doubled its company size as well as added therapeutic categories to portfolio of services.
Upon closing, BioMatrix's national footprint increases to 11 pharmacy locations, nationwide, in key metropolitan locations. Elwyn joins the rapidly growing family of companies that comprise BioMatrix including Matrix Health Group, Factor Support Network, Medex BioCare, and BiologicTx.
genedrive secures initial overseas orders for Genedrive MT-RNR1 ID kit
Kromek collaborates on next-gen CT detector technology
Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention
European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV
Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring
Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus
Seres Therapeutics provides business updates and reports Q2 2023 financial results